Research strategies for safety evaluation of nanomaterials, Part I: evaluating the human health implications of exposure to nanoscale materials.
about
Facets of Nanotechnology as Seen in Food Processing, Packaging, and Preservation IndustryNanomedicine applications in orthopedic medicine: state of the artHigh resolution characterization of engineered nanomaterial dispersions in complex media using tunable resistive pulse sensing technologyNanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.Principal component and causal analysis of structural and acute in vitro toxicity data for nanoparticles.Reversal in multidrug resistance by magnetic nanoparticle of Fe3O4 loaded with adriamycin and tetrandrine in K562/A02 leukemic cellsComparative iron oxide nanoparticle cellular dosimetry and response in mice by the inhalation and liquid cell culture exposure routes.Risks from accidental exposures to engineered nanoparticles and neurological health effects: a critical review.Retinopathy Induced by Zinc Oxide Nanoparticles in Rats Assessed by Micro-computed Tomography and Histopathology.Manganese nanoparticle activates mitochondrial dependent apoptotic signaling and autophagy in dopaminergic neuronal cellsIn vivo evaluation of carbon fullerene toxicity using embryonic zebrafish.Reversal of multidrug resistance by cisplatin-loaded magnetic Fe3O4 nanoparticles in A549/DDP lung cancer cells in vitro and in vivoReversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine in xenograft nude-miceThe reversal effect of magnetic Fe3O4 nanoparticles loaded with cisplatin on SKOV3/DDP ovarian carcinoma cellsEffects of intraperitoneally injected silver nanoparticles on histological structures and blood parameters in the albino rat.Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices.Fourier-transform infrared spectroscopy for rapid screening and live-cell monitoring: application to nanotoxicology.Assessing nanoparticle risk poses prodigious challenges.Activation of stress-related signalling pathway in human cells upon SiO2 nanoparticles exposure as an early indicator of cytotoxicity.Nanotechnology: History and future.Silver nanoparticles (AgNPs) cause degeneration of cytoskeleton and disrupt synaptic machinery of cultured cortical neurons.Effect of Clinoptilolite and Sepiolite Nanoclays on Human and Parasitic Highly Phagocytic Cells.Al₂O₃ nanoparticles induce mitochondria-mediated cell death and upregulate the expression of signaling genes in human mesenchymal stem cells.Financial disclosure and toxic products: encouraging wall street to anticipate product risk and exercise precaution.Multiwall Carbon Nanotube-Induced DNA Damage and Cytotoxicity in Male Human Peripheral Blood Lymphocytes.Algatrium® and antioxidant response - Scientific substantiation of a health claim related to Algatrium® and antioxidant response Article 13(5) of Regulation (EC) No 1924/2006Research strategies for safety evaluation of nanomaterials, part II: toxicological and safety evaluation of nanomaterials, current challenges and data needs.Characterization of the size, shape, and state of dispersion of nanoparticles for toxicological studiesHuman-related application and nanotoxicology of inorganic particles: complementary aspects
P2860
Q26776374-C585EF3F-1E76-4171-9498-9C27C558135DQ26785640-78321150-5BBA-466C-AAF1-BE2FE1AB4517Q28394762-D93AABEB-A782-4BD1-A022-83F39F0F9F70Q30387307-E52DEEE9-E42A-4694-BD8B-E6337DC9DCF8Q30616632-5B943B57-763B-4A21-81F6-1D391A371D9CQ33358484-B7D66E7A-FC8B-4841-8A09-9349E1E35E8FQ34355384-851DF100-842F-46A3-9B16-08DFE2BF842CQ34468073-788EB7C9-5041-40CD-AE22-0529A62EF51CQ34485870-C7718DC3-2A38-4480-8B73-590A383DFB40Q35489449-ED5CD48F-DF6D-4728-A770-C7A062A1254CQ36344411-A3492637-62FA-4A0B-AFAC-D5060A9C4E58Q36851857-4FC7F7A8-FE28-4DA7-B76D-C647B0587E68Q37288967-A4AA3F08-0B85-4F67-95B5-DE32A03D3C9DQ37289000-634D129D-8B00-481E-9719-9B606080A3F7Q37671616-0C66BC70-AFC2-4230-8361-251386C963CAQ37854600-F52EE5B8-5A57-4FEC-9F5F-601F3E4E56E6Q38068917-9ACE6FF0-F985-428D-AC0F-3640E3C0239FQ38097389-DBEE758B-CC2B-4785-AE73-2DF390343C95Q38275446-904FE470-B989-450B-B4A8-6A8864F2958BQ38651285-1E3FABE4-7A97-4C32-BFE2-32113B0FDECAQ41503484-C39D8265-A8E4-467F-833C-0B11BDF98565Q41560765-2237700C-BB1A-455A-BD0B-33F91F2A3BBEQ42714406-54616D9D-1078-4488-AEFD-51BF198D1AC8Q46008690-59DF065C-472C-4BB9-9B0C-A7BDCD7A024DQ46685094-45F7D9B2-BB58-49A5-BA86-05226584D54EQ47146440-10B3F4BB-0512-4E47-80BB-4B6D469334C4Q50768263-3F856890-51EC-4982-AFCD-1422913D83DAQ56483155-A5D02764-DA60-47A4-8BC1-0CCCE7D40998Q57766071-05812B0D-A66C-45A6-AFD8-EA8728B98AF1
P2860
Research strategies for safety evaluation of nanomaterials, Part I: evaluating the human health implications of exposure to nanoscale materials.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Research strategies for safety ...... posure to nanoscale materials.
@ast
Research strategies for safety ...... posure to nanoscale materials.
@en
type
label
Research strategies for safety ...... posure to nanoscale materials.
@ast
Research strategies for safety ...... posure to nanoscale materials.
@en
prefLabel
Research strategies for safety ...... posure to nanoscale materials.
@ast
Research strategies for safety ...... posure to nanoscale materials.
@en
P356
P1476
Research strategies for safety ...... posure to nanoscale materials.
@en
P2093
Karluss Thomas
Philip Sayre
P304
P356
10.1093/TOXSCI/KFI270
P577
2005-07-27T00:00:00Z